康臣药业(01681)公布，2025年10月20日耗资约154.13万港元回购10万股股份。 ...

Group 1 - The company, Kangchen Pharmaceutical (01681.HK), announced a share buyback plan on October 20, 2025, involving an expenditure of HKD 1.54 million to repurchase 100,000 shares [1] - The buyback price range is set between HKD 15.39 and HKD 15.47 per share [1]

Core Viewpoint - 康臣药业 announced a share buyback plan, indicating a strategic move to enhance shareholder value by repurchasing 100,000 shares at a cost of approximately HKD 1.5413 million [1] Company Summary - 康臣药业 plans to repurchase 100,000 shares on October 20, 2025 [1] - The total expenditure for this buyback is around HKD 1.5413 million [1]

表格類別： 股票 狀態： 新提交 FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 公司名稱： 康臣葯業集團有限公司 呈交日期： 2025年10月20日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 01681 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔有 ...

Summary of Key Points Core Viewpoint - On October 17, 42 Hong Kong-listed companies conducted share buybacks, totaling 46.36 million shares and an aggregate amount of HKD 621 million [1][2]. Company-Specific Summaries - **Xiaomi Group-W**: - Repurchased 10.70 million shares for HKD 494 million, with a highest price of HKD 46.760 and a lowest price of HKD 45.900. The total buyback amount for the year reached HKD 1.537 billion [1][2]. - **Sihuan Pharmaceutical**: - Repurchased 15 million shares for HKD 21.76 million, with a highest price of HKD 1.470 and a lowest price of HKD 1.430. The total buyback amount for the year reached HKD 143.32 million [1][2]. - **Mengniu Dairy**: - Repurchased 1.20 million shares for HKD 16.97 million, with a highest price of HKD 14.250 and a lowest price of HKD 14.070. The total buyback amount for the year reached HKD 433.54 million [1][2]. - **AAC Technologies**: - Repurchased 300,000 shares for HKD 11.60 million, with a highest price of HKD 38.800 and a lowest price of HKD 38.480. The total buyback amount for the year reached HKD 84.64 million [1][2]. - **Vitasoy International**: - Repurchased 1.02 million shares for HKD 8.20 million, with a highest price of HKD 8.040 and a lowest price of HKD 8.020. The total buyback amount for the year reached HKD 27.54 million [1][2]. Overall Market Activity - The highest buyback amount on October 17 was from Xiaomi Group-W at HKD 494 million, followed by Sihuan Pharmaceutical at HKD 21.76 million. Other notable companies included Mengniu Dairy and AAC Technologies [1][2]. - In terms of share quantity, Sihuan Pharmaceutical led with 15 million shares repurchased, followed by Xiaomi Group-W with 10.70 million shares and Anton Oilfield Services with 4.49 million shares [1][2].

Core Viewpoint - Multiple companies in China conducted share buybacks on October 17, 2025, with Xiaomi Group-W leading in terms of buyback amount and quantity [1][2] Group 1: Buyback Details - Xiaomi Group-W (01810) repurchased 10.70 million shares for a total of 494 million yuan, with a year-to-date total of 27.30 million shares, representing 0.110% of its total share capital [2] - Four Seasons Pharmaceutical (00460) repurchased 15 million shares for 21.76 million yuan, with a year-to-date total of 59.60 million shares, representing 0.647% of its total share capital [2] - Mengniu Dairy (02319) repurchased 1.20 million shares for 16.97 million yuan, with a year-to-date total of 18.52 million shares, representing 0.473% of its total share capital [2] Group 2: Other Notable Buybacks - VITASOY International (00345) repurchased 1.02 million shares for 8.20 million yuan, with a year-to-date total of 566.60 million shares, representing 0.540% of its total share capital [2] - Zhongtong Express-W (02057) repurchased 445,000 shares for 8.41 million yuan, with a year-to-date total of 5.07 million shares, representing 0.630% of its total share capital [2] - Huazhong Media (00685) repurchased 500,000 shares for 50,000 yuan, with a year-to-date total of 225.60 million shares, representing 0.139% of its total share capital [2]

Core Viewpoint - 康臣药业 has been actively repurchasing its shares, indicating a strategy to support its stock price amidst recent declines [2][3] Summary by Category Share Buyback Activity - On October 17, 康臣药业 repurchased 317,000 shares at a price range of HKD 14.970 to HKD 15.200, totaling HKD 4.7791 million [2] - The stock closed at HKD 15.070 on the same day, reflecting a decrease of 2.65% with a total trading volume of HKD 22.5955 million [2] - Since October 14, the company has conducted buybacks for four consecutive days, acquiring a total of 937,000 shares for a cumulative amount of HKD 14.368 million, during which the stock price fell by 5.81% [2] Year-to-Date Buyback Summary - Year-to-date, 康臣药业 has executed 22 buyback transactions, repurchasing a total of 6.132 million shares for a total expenditure of HKD 72.8991 million [2] Detailed Buyback Data - The buyback details include: - October 16: 200,000 shares at a maximum price of HKD 15.600, totaling HKD 3.1182 million [2] - October 15: 100,000 shares at a maximum price of HKD 15.840, totaling HKD 1.5757 million [2] - October 14: 320,000 shares at a maximum price of HKD 15.620, totaling HKD 4.8951 million [2] - Other notable buyback dates include July 18, July 16, and July 15, with varying amounts and prices [2][3]

康臣药业(01681)发布公告，公司于2025年10月17日斥资477.91万港元回购31.7万股股份，每股回购价格 为14.97-15.2港元。 ...

Group 1 - The company, 康臣药业 (Kangchen Pharmaceutical), announced a share buyback on October 17, 2025, spending HKD 4.7791 million to repurchase 317,000 shares [1] - The buyback price ranged from HKD 14.97 to HKD 15.20 per share [1]

Core Viewpoint - 康臣药业 announced a share buyback plan, indicating confidence in its stock value and potential for future growth [1] Group 1: Company Actions - 康臣药业 plans to repurchase 317,000 shares at a total cost of HKD 4.7791 million [1] - The buyback price per share ranges from HKD 14.97 to HKD 15.20 [1]